Get started
Author

Federica Tomao

Observed names: F Tomao, F. Tomao, F., Tomao, FEDERICA TOMAO, S Tomao, S. Tomao, Silverio Tomao, TOMAO, FEDERICA, Tomao F, Tomao, Federica, Tomao, S.
Observed institutions: Mario Negri Institute for Pharmacological Research, University of L'Aquila, Policlinico Umberto I, American Association For Cancer Research, Richmond University Medical Center, University of Chieti-Pescara, Azienda Ospedaliera di Perugia, Istituto per lo Studio e la Prevenzione Oncologica, Azienda Ospedaliera San Camillo-Forlanini, Ospedale di Cattinara, Città di Castello Hospital, Azienda Ospedaliera Santa Maria Degli Angeli, Azienda Ospedaliero-Universitaria Careggi, Azienda Ospedaliera Sant'Andrea, Ospedale Regina Margherita, Consorzio Interuniversitario Nazionale per la Bio-Oncologia, University Hospital of Heraklion, Ospedale Santa Maria Goretti, National Cancer Center of Georgia, Carlo Forlanini Hospital, Instituto Nazionale Tumori Regina Elena, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele, Azienda sanitaria universitaria Giuliano Isontina, University of Florence, European Institute of Oncology, University of Milano-Bicocca, Sapienza University of Rome
ORCID: 0000-0002-9738-3102
Observed ORCID: 0000-0002-9738-3102
OpenAlex ID: A5072059804
Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa–Associated Lymphoid Tissue Lymphoma
2009 · Angelo Zullo, Cesare Hassan, et al. · Clinical Gastroenterology and Hepatology · 316
PDF
Triple-negative breast cancer: new perspectives for targeted therapies
2015 · Silverio Tomao, Federica Tomao, et al. · OncoTargets and Therapy · 137
PDF
Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months
2018 · Stefania Rizzo, Francesca Botta, et al. · European Radiology · 133
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
2014 · Claudia Marchetti, Margherita Giorgini, et al. · OncoTargets and Therapy · 132
PDF
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
2019 · E. Krasniqi, G. Barchiesi, et al. · Journal of Hematology & Oncology · 128
PDF
Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC
2008 · F. Di Costanzo, S. Gasperoni, et al. · JNCI Journal of the National Cancer Institute · 128
PDF
Gastric pathology in patients with common variable immunodeficiency
1999 · A Zullo, A Romiti, et al. · Gut · 126
PDF
Bevacizumab in ovarian cancer: A critical review of phase III studies
2016 · Luigi Rossi, Monica Verrico, et al. · Oncotarget · 114
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis
2014 · Federica Zoratto, Luigi Rossi, et al. · Tumor Biology · 110
Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday
2018 · Roberta Lazzari, Sara Ronchi, et al. · International Journal of Radiation Oncology*Biology*Physics · 97
PDF
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies
2016 · P Vici, L Pizzuti, et al. · Expert Review of Vaccines · 97
PDF
Emerging Role of PARP Inhibitors in Metastatic Triple Negative Breast Cancer. Current Scenario and Future Perspectives
2021 · Giacomo Barchiesi, Michela Roberto, et al. · Frontiers in Oncology · 96
PDF
Eradication Therapy for Helicobacter pylori in Patients With Gastric MALT Lymphoma: A Pooled Data Analysis
2009 · Angelo Zullo, Cesare Hassan, et al. · The American Journal of Gastroenterology · 94
Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study
2014 · Maria Porpora, Federica Tomao, et al. · Journal of Ovarian Research · 92
PDF
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach
2013 · Federica Tomao, Anselmo Papa, et al. · Journal of Experimental & Clinical Cancer Research · 92
PDF
Immune effects of CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: Relief from immunosuppression is associated with clinical response
2022 · Fabio Scirocchi, Simone Scagnoli, et al. · EBioMedicine · 86
PDF
Angiogenesis and antiangiogenic agents in cervical cancer
2014 · Silverio Tomao, Federica Tomao, et al. · OncoTargets and Therapy · 84
PDF
Toxicity of Targeted Therapy in Non–Small-Cell Lung Cancer Management
2009 · Serena Ricciardi, Silverio Tomao, et al. · Clinical Lung Cancer · 83
Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum‐free interval: Myth or reality?
2017 · Federica Tomao, Maurizio D'Incalci, et al. · Cancer · 82
PDF
Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status
2019 · Federica Tomao, Erlisa Bardhi, et al. · Cancer Treatment Reviews · 79
Eradication Therapy in Helicobacter pylori-negative, Gastric Low-grade Mucosa–associated Lymphoid Tissue Lymphoma Patients
2013 · Angelo Zullo, Cesare Hassan, et al. · Journal of Clinical Gastroenterology · 79
Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
2008 · Evelina Miele, Gian Paolo Spinelli, et al. · Journal of Experimental & Clinical Cancer Research · 79
PDF
Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
2020 · Innocenza Palaia, Federica Tomao, et al. · OncoTargets and Therapy · 76
PDF
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment
2016 · Anselmo Papa, Davide Caruso, et al. · Journal of Translational Medicine · 75
PDF
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
2020 · Giulia Bon, Laura Pizzuti, et al. · Journal of Experimental & Clinical Cancer Research · 74
PDF
Works count: 466
Citation count: 8,693
H-index: 48
I10-index: 214
Year
Topic
Type